Astellas(ALPMY) - 2020 Q2 - Earnings Call Presentation

Q2/FY2020 FINANCIAL RESULTS ENDED SEPTEMBER 30, 2020 Kenji Yasukawa, Ph.D. President and CEO Astellas Pharma Inc. October 30, 2020 CAUTIONARY STATEMENT REGARDING FORWARDLOOKING INFORMATION 2 In this material, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas Pharma. These statements are based on management's current assumptions and beliefs in light of the ...